Detect lung cancer with a nanotech breathalizer? It works, four out of five times, could revolutionize cancer screening

Researchers have been working for several years on a way to detect lung cancer in patients by analyzing their breath. It appears that they are close to having a working device. An international team of researchers presented their work, a breath test that can detect lung cancer, at the recent American Society of Clinical Oncology meeting in Chicago. The researchers reported that the device could accurately detect lung cancer in four out of five cases. A small version of the device can plug into a computer’s USB port.

The device, which can detect the unique smell of cancer cells, can ever differentiate between subtypes, and can tell how advanced the disease is. Study author Dr. Nir Peled, an oncologist with the Davidoff Cancer Center in Israel explained, “The more tumor you have, the more robust signature you produce.”

breathalyzer-nanotechnology-volatile-organic-compounds-VOC-medical-research-oncology-cancer-lung-diagnosis-EDIWeekly
A lung cancer breathalyzer could substantially impact survival rates. Researchers have developed a device that works with up to 90 per cent accuracy in detecting lung cancer by analyzing volatile organic compounds in the patients’ breath.

The device could “totally revolutionize” lung cancer screening and diagnosis, Peled said. It can provide a “nontraumatic, easy, cheap approach to early detection and differentiation of lung cancer,” said study co-author Dr. Fred Hirsch, an investigator at the University of Colorado Cancer Center and professor at the University of Colorado School of Medicine in Denver.

Lung cancer is the top cancer killer in the United States. The tumors produce volatile organic compounds (VOCs), which the device’s NaNose nanotech chip can detect from a person’s breath. The ability to detect tumors earlier would be a big advantage and could “substantially impact survival.”

In the tests, conducted in the United States and in Israel, patients blew into a balloon that was attached to a gold nanoparticle sensor. Particles trapped in the sensor were analyzed for VOCs. Early-stage lung cancer patients were identified 85 per cent of the time; healthy people were distinguished from those with advanced-stage lung cancer 82 per cent of the time.

US company Alpha Szenszor has acquired the licence for the technology and is working to bring it to market “within the next few years.”

Did you miss this?

Other Popular Stories

  • Zinc-air battery shows great promise in search for energy storage
  • Windsor auto industry growing, needs skilled workers: report
  • Ontario Energy Board to ban door-to-door selling of energy
  • Valves essential component of safe oil pipeline
  • NASA and Nissan to build autonomous vehicles together
  • Green building technology to grow annually by 10.12% to the year 2023
  • Canada-France space agencies test stratosphere balloon in Ontario
  • Acquisition of SABMiller makes Molson Coors third-largest brewer in the world
  • Large electric aircraft feasible with record-breaking Siemens motor
  • Building code change could help drain water heat recovery manufacturers
  • Ontario and Saskatchewan criticizes the Federal Canadian Minerals and Metals Plan in a joint official statement
  • Aerospace industry pleased with $1 billion funding in budget
  • US moves to cut coal-fired emissions highlight rift with Canada
  • Windsor's good fortune with Chrysler hiring tempered by TPP concerns
  • Blowing up the Moon for Water? Space Miners Aim to "Mine Water" as Early as 2023
  • 3D printed hempcrete could revolutionize construction industry
  • Canada Goose expanding workforce, launching global ad campaign
  • Irving Shipbuilding looking to lure workers back east from Alberta
  • Goodbye NAFTA, Hello USMCA trade deal: it's not all in the name — Canadian dollar soars, stocks rise; autos win, dairy loses
  • The challenges of 3D printing or manufacturing in space — without gravity to help it all "stick"
Scroll to Top